Log In
Print this Print this

UniFluVec (VTH 201)

  Manage Alerts
Collapse Summary General Information
Company Vacthera BioTech GmbH
DescriptionIntranasal vaccine based on genetically modified influenza A virus
Molecular Target Influenza antigen
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsTreat influenza A virus infection; Treat influenza B virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today